The Big Moves in Overtime - Christina Parts and Double Losses

Gilead Sciences, the biotech firm crushing fourth quarter expectations and issuing an unexpectedly bullish outlook. Atlassian cloud provider under serious pressure right now missing Q2 estimates on revenue, but topping the street on earnings. Will the NASDAQ outperform the S&P 500 this year? Want to know what you think had to add to NBC overtime on Twitter to vote? We'll share the results coming up before we end our show here and overtime up next.